Mangoceuticals receives RFP from ISFLST for male enhancement product

Mangoceuticals announced the receipt of its first Request for Proposal from its distributor, the International Society of Frontier Life Sciences and Technology This RFP focuses on the formulation, production, and packaging of a new male enhancement non-prescription product, intended to be introduced and sold in the Chinese market as a natural solution for men’s health. This collaboration aligns MangoRx’s advanced formulation, manufacturing, branding capabilities and commitment to quality with ISFLST’s vision for a superior men’s health and enhancement product. The proposed product will be manufactured in the USA, utilizing GMP-compliant facilities. The anticipated pilot program will explore initial distribution across 50 retail locations throughout China, with the potential to scale to up to 5,000 locations based on market demand analysis. Dr. Douglas Christianson, the Company’s Director of Medical Research and Product Innovation will be spearheading the RFP process and will be working closely with our partners at the ISFLST to develop and finalize the male enhancement product’s formulation. The initiative to address the need for innovative men’s health products has been well received by the region, with several associations preparing for their market launch. As the men’s health platform gains traction, the ISFLST has also expressed interest in developing similar solutions for women’s health.